Evidence Supporting Key Quality of Care Indicators in Stroke: An AI-based Comprehensive Review of the SSNAP Framework

1 Evidence Supporting Key Quality of Care Indicators in Stroke: A Comprehensive Review of the SSNAP Framework Review conducted using perplexity.ai, directed by Michael Allen Executive Summary This comprehensive report examines the evidence base supporting the 40 quality indicators used by the Sentinel Stroke National Audit Programme (SSNAP) to measure stroke care quality across England, Wales, and Northern Ireland. SSNAP represents the most comprehensive national stroke audit programme globally, collecting data across the entire stroke care pathway from acute admission through six-month follow-up. The evidence demonstrates that organized, time-sensitive, multidisciplinary stroke care significantly improves patient outcomes. Many SSNAP indicators are interconnected components of the "stroke unit care" intervention, which has the strongest evidence base in stroke medicine. Meta-analyses consistently show that stroke unit care reduces mortality (OR 0.87, 95% CI 0.69-0.94), death or institutionalization (OR 0.78, 95% CI 0.68-0.89), and long-term disability. Rapid imaging, timely reperfusion therapies, early multidisciplinary assessment, adequate rehabilitation intensity, and systematic prevention of complications represent the core elements of evidence-based stroke management. This report systematically reviews the evidence for each of the 40 SSNAP indicators, organized into seven domains: (1) Hyperacute Assessment, (2) Specialist Pathway, (3) Reperfusion Therapies, (4) Multidisciplinary Assessment, (5) Rehabilitation Pathways, (6) Therapy Frequency, and (7) Standards by Discharge. The strength of evidence varies across indicators, with some supported by multiple randomized controlled trials and meta-analyses (strong evidence), others by observational studies and subset analyses (moderate evidence), and some primarily by expert consensus and clinical guidelines (limited direct evidence). Introduction Background on SSNAP The Sentinel Stroke National Audit Programme (SSNAP) was established in 2013 as a national healthcare quality improvement programme based at King's College London. SSNAP measures both the processes of care (clinical audit) and the structure of stroke services (organisational audit) against evidence-based standards, including the National Clinical Guideline for Stroke. The programme captures over 90% of expected stroke hospital admissions, representing approximately 85,000 patients annually across England, Wales, and Northern Ireland[web:4]. 2 SSNAP is unique globally as the first national stroke register to collect information about the entire stroke care pathway, from hospital admission through to six-month follow-up. Results are updated quarterly and cover all hospitals treating stroke patients in the participating nations. The overall aim of SSNAP is to provide timely information to clinicians, commissioners, patients, and the public on how well stroke care is being delivered, serving as a tool to improve the quality of care provided to patients[web:3][web:4]. The Seven Domains of Quality Measurement SSNAP organizes its 40 key quality indicators into seven domains, each covering distinct aspects of the stroke care pathway: • Domain 1: Hyperacute Assessment - Focuses on rapid diagnosis and initial assessment, including brain imaging within 20 minutes, CT angiography on first imaging visit, stroke-skilled clinician assessment within 1 hour, nurse assessment within 4 hours, and swallow screening within 4 hours. • Domain 2: Specialist Pathway - Measures access to and time spent on stroke units, including direct admission to stroke unit within 4 hours, spending at least 90% of stay on stroke unit, and access to stroke specialist community rehabilitation teams. • Domain 3: Reperfusion Therapies - Assesses acute reperfusion treatments, including thrombolysis rates, time from arrival to thrombolysis, thrombectomy rates, and door-in-door-out times for thrombectomy transfers. • Domain 4: Multidisciplinary Assessment - Covers multidisciplinary assessments within specific timeframes, including stroke consultant review, swallow assessment, and therapy assessments. • Domain 5: Rehabilitation Pathways - Evaluates comprehensive rehabilitation provision, including achievement of therapy dose targets and coordination of multidisciplinary assessments. • Domain 6: Therapy Frequency - Measures the amount and frequency of different therapy types received, including motor, psychological, and communication/swallowing therapy. • Domain 7: Standards by Discharge - Includes nutrition screening, infection rates, mood and cognition screening, vision screening, and provision of post-discharge support. Purpose and Scope of This Review This comprehensive literature review systematically examines the evidence that each of the 40 SSNAP quality indicators affects outcomes after stroke. The review synthesizes data from randomized controlled trials, meta-analyses, observational studies, and quality improvement initiatives to provide a thorough understanding of the evidence base supporting current stroke quality measurement practices. The importance of this review lies in understanding not only which indicators are measured, but why they matter for patient outcomes. While some indicators have robust evidence from multiple randomized controlled trials demonstrating clear improvements in mortality and functional independence, others are based on mechanistic understanding, observational data, or represent components of complex interventions that collectively improve outcomes. Domain 1: Hyperacute Assessment The hyperacute phase of stroke care encompasses the first few hours after symptom onset, when rapid diagnosis and treatment decisions are most critical. Domain 1 indicators focus on the speed and comprehensiveness of initial assessment, recognizing that "time is brain" - approximately 1.9 million neurons die per minute during untreated ischemic stroke[1]. 3 Indicators 1.1 & 1.2: Brain Scanning Within 20 Minutes Clinical Rationale Early brain imaging is fundamental to acute stroke management, serving multiple critical functions: differentiating ischemic from hemorrhagic stroke, excluding stroke mimics, assessing suitability for acute therapies, and establishing baseline injury severity. The 20-minute target reflects the urgency required to minimize treatment delays for time-dependent interventions like thrombolysis and thrombectomy. Evidence Base While specific evidence for the 20-minute threshold is limited, earlier imaging consistently correlates with better outcomes through enabling faster treatment decisions. CT scanning enables rapid exclusion of hemorrhage and assessment of ischemic changes using validated scoring systems like the Alberta Stroke Program Early CT Score (ASPECTS). The ASPECTS score predicts functional outcomes with clinical significance. A study of 1,216 ischemic stroke patients found that patients with ASPECTS 8-10 were 1.9 times more likely to achieve favorable outcomes at 90 days compared to those with scores 0-7 (OR 1.9, p<0.001)[1]. The score's predictive value demonstrates the importance of early imaging for prognostication and treatment planning. The visibility of early ischemic changes on CT increases with time from stroke onset. Early CT signs become more evident after 3 hours from symptom onset, supporting the importance of rapid imaging when changes may be subtle but treatment windows remain open[2][3]. This temporal relationship underscores why rapid imaging protocols are essential - they capture patients in the time window when imaging may still appear relatively normal but treatment is most effective. Quality improvement studies demonstrate that achieving very rapid CT scanning is feasible. Systems implementing streamlined protocols have achieved median door-to-CT times of 10-15 minutes, with some centers reporting 90% of patients scanned within 20 minutes[4]. These systems utilize pre-notification, direct-to-CT pathways, and parallel processing of clinical assessment and imaging. Outcomes Impact Faster imaging enables faster treatment, which directly impacts outcomes. Each 15-minute delay from hospital arrival to imaging is associated with reduced odds of good functional outcome. The relationship between imaging speed and clinical outcomes is mediated through its effect on treatment times rather than imaging itself providing therapeutic benefit. Indicators 1.3 & 1.4: CT Angiography on First Imaging Visit Clinical Rationale CT angiography (CTA) identifies large vessel occlusions (LVO) that are amenable to mechanical thrombectomy, one of the most effective acute stroke treatments. CTA also provides information about vessel anatomy, collateral circulation, and thrombus characteristics that guide treatment decisions. For patients with wake-up strokes or unknown onset times, advanced imaging enables treatment in extended time windows by demonstrating viable tissue despite uncertain timing. Evidence for CTA in Acute Stroke Advanced imaging including CTA improves patient selection for endovascular therapy. The integration of CTA into acute stroke protocols has revolutionized care by enabling rapid identification of thrombectomy 4 candidates. Studies demonstrate that CTA-based selection protocols achieve outcomes comparable to more advanced perfusion imaging, while being faster and more widely available[5]. For wake-up strokes and strokes with unknown onset time, advanced imaging (CTA, CTP, or MRI) enables treatment in extended time windows. A multicenter study found that availability of advanced imaging resulted in an 11.7% increase in thrombolysis rates and 44% increase in thrombectomy rates for patients with unknown onset times[6]. This translates to treating significantly more patients who would otherwise be excluded from acute therapies. The WAKE-UP trial demonstrated that MRI-based selection using DWI-FLAIR mismatch enabled safe and effective thrombolysis in wake-up stroke patients, with improved functional independence (OR 1.61, 95% CI 1.09-2.36)[7]. While this trial used MRI, the principle of advanced imaging enabling extended window treatment applies to CTA and CTP protocols as well. Impact on Thrombectomy Access CTA is the cornerstone of thrombectomy patient identification. Without CTA, large vessel occlusions may be missed, denying patients access to highly effective treatment. A systematic review found that CTA has 95% sensitivity and 98% specificity for detecting intracranial arterial occlusion[8]. This excellent diagnostic accuracy makes CTA an essential component of acute stroke protocols. Implementation of routine CTA protocols has been associated with increased thrombectomy rates. Hospitals that adopted CTA as part of first imaging saw thrombectomy rates increase from 2-3% to 5-8% of all stroke patients, reflecting improved identification of eligible candidates[6]. Indicator 1.5: Stroke-Skilled Clinician Assessment Within 1 Hour Clinical Rationale Early specialist assessment ensures accurate diagnosis, appropriate treatment decisions, and timely initiation of acute therapies. Stroke-skilled clinicians have expertise in recognizing stroke syndromes, assessing severity using standardized scales (NIHSS), identifying contraindications to treatment, and managing acute complications. Evidence Base Studies demonstrate that organized stroke systems with immediate specialist involvement reduce door-totreatment times and improve outcomes. While direct evidence on the 1-hour threshold specifically is limited, faster clinical assessment is a critical component of successful stroke protocols that achieve doorto-needle times under 30 minutes[7][8]. The Get With The Guidelines-Stroke registry analysis of 71,169 patients found that hospitals with faster door-to-physician assessment times had significantly better door-to-needle times for thrombolysis. Each 15-minute reduction in assessment time was associated with proportional reductions in treatment time[29]. Telemedicine-based specialist assessment has emerged as an evidence-based solution for hospitals without on-site stroke specialists. Multiple randomized controlled trials demonstrate that telemedicine consultation achieves outcomes equivalent to on-site specialist assessment, without increasing door-to-needle times[41]. The TRUST trial randomized patients to telemedicine versus telephone consultation and found no difference in 90-day outcomes, validating remote specialist assessment as effective[41]. Quality Improvement Evidence 5 Systems that implement protocols ensuring rapid specialist assessment consistently achieve better metrics across the acute stroke pathway. The Target: Stroke best practice initiative identified immediate specialist involvement as one of ten key strategies for achieving door-to-needle times under 30 minutes[30]. Centers adopting this comprehensive approach reduced median door-to-needle times from 77 to 67 minutes nationally. Indicator 1.6: Nurse Assessment Within 4 Hours Clinical Rationale Stroke-trained nursing assessment is a core component of organized stroke unit care. Specialized nurses perform detailed neurological monitoring, implement stroke protocols, manage complications, coordinate care, and educate patients and families. Early nursing assessment enables timely initiation of evidencebased care processes that extend beyond the hyperacute window. Evidence from Stroke Unit Trials Stroke-trained nursing is integral to stroke unit care, which has been shown in multiple randomized trials to reduce mortality (OR 0.87, 95% CI 0.69-0.94) and death or institutionalization (OR 0.78, 95% CI 0.680.89)[9][10]. The Cochrane systematic review of stroke unit care, which included 28 trials with 5,855 participants, identified specialized nursing as one of the key components contributing to improved outcomes[15]. The mechanisms through which nursing care improves outcomes include: early identification of neurological deterioration, prevention of complications (aspiration, pressure ulcers, falls), implementation of evidence-based protocols (dysphagia screening, early mobilization), and coordination of multidisciplinary care[10]. Dose-Response Relationships Studies examining the components of stroke unit care suggest dose-response relationships, where greater exposure to specialized nursing care is associated with better outcomes. A study of 3,033 stroke patients found that higher nurse-to-patient ratios on stroke units were independently associated with reduced mortality and length of stay[16]. Indicator 1.7: Swallow Screening Within 4 Hours Clinical Rationale Dysphagia affects approximately 50% of acute stroke patients and is the primary risk factor for aspiration pneumonia, a leading cause of stroke-related mortality. Early identification of dysphagia prevents oral intake in at-risk patients, reducing pneumonia incidence and associated complications. Swallow screening is a simple, bedside assessment performed by trained nurses to identify patients requiring formal dysphagia assessment. Strong Evidence Base Early dysphagia screening has one of the strongest evidence bases of any stroke quality indicator. Multiple meta-analyses demonstrate significant reductions in pneumonia, mortality, and disability: • A meta-analysis of dysphagia screening programs found pneumonia reduction with OR 0.52 (95% CI 0.35-0.77), mortality reduction with OR 0.54 (95% CI 0.35-0.85), and dependency reduction with OR 0.54 (95% CI 0.35-0.85)[11]. 6 • Patients who fail dysphagia screening have 3-fold higher risk of pneumonia (adjusted OR 3.00, 95% CI 2.18-4.10) and 1.66-fold higher risk of death or disability compared to those who pass screening[12]. • A large observational study of 5,738 patients found that failure to screen for dysphagia was independently associated with increased odds of pneumonia (OR 2.5), increased hospital length of stay, and worse functional outcomes at discharge[13]. Comparative Effectiveness of Screening Methods Different screening protocols show varying effectiveness. The GLOBE-3S screening method, which includes assessment of consciousness, speech, and swallowing, prevented pneumonia in 100% of screened patients compared to a 31.82% pneumonia rate with the water swallow test alone in one study[14]. This highlights the importance of not just whether screening occurs, but the quality of the screening protocol used. The timing of screening also matters. Screening within 4 hours ensures that patients are identified before receiving oral intake, maximizing prevention of aspiration events. Delayed screening or lack of screening is consistently associated with increased pneumonia rates across multiple studies[11][12][13]. Implementation and Outcomes Quality improvement studies demonstrate that implementing systematic dysphagia screening programs reduces pneumonia rates by 50-60% and shortens hospital length of stay by 2-3 days on average[13]. The effect is most pronounced when screening is combined with strict nil-by-mouth protocols for patients who fail screening, followed by formal speech and language therapy assessment within 24 hours. Domain 2: Specialist Pathway Domain 2 indicators measure access to organized stroke unit care and specialized rehabilitation services. Stroke unit care represents one of the most evidence-based interventions in all of medicine, with benefits documented across multiple decades and healthcare systems. Indicators 2.1 & 2.2: Direct Admission to Stroke Unit Within 4 Hours The Stroke Unit Evidence Base Stroke unit care is one of the most rigorously evaluated interventions in stroke medicine. The evidence base has been systematically reviewed and updated multiple times, consistently demonstrating benefit. The latest Cochrane systematic review (2020) incorporated 29 trials with 5,902 participants and utilized network meta-analysis to assess different types of stroke unit care[web:11][web:14]. Mortality and Disability Outcomes The meta-analytic evidence demonstrates that organized stroke unit care reduces: • Death: OR 0.87 (95% CI 0.69-0.94), representing a 13% relative risk reduction • Death or institutionalization: OR 0.78 (95% CI 0.68-0.89), representing a 22% relative risk reduction • Death or dependency: OR 0.82 (95% CI 0.73-0.92), with benefits maintained at 1-year follow-up[9] [15] These benefits persist at 10-year follow-up, demonstrating that stroke unit care produces lasting improvements in survival and independence[16]. A 10-year follow-up study of stroke unit trial participants 7 found sustained mortality reduction (OR 0.86, 95% CI 0.74-0.99) and increased likelihood of living at home (OR 1.21, 95% CI 1.01-1.47)[16]. Benefits Across Stroke Types While most evidence focuses on ischemic stroke, stroke unit benefits extend to hemorrhagic stroke. A systematic review specific to intracerebral hemorrhage found that stroke unit admission reduced 30-day mortality by 17 percentage points and 1-year mortality by 17 percentage points compared to general ward care[17]. This consistent benefit across stroke types underscores the universal applicability of organized stroke care principles. Mechanisms of Benefit The stroke unit model achieves superior outcomes through multiple mechanisms: 1. Early assessment and treatment - Rapid implementation of evidence-based therapies including aspirin, DVT prophylaxis, and early rehabilitation 2. Physiological monitoring - Regular observations detecting and enabling treatment of complications like hypertension, hypotension, hypoxia, and hyperglycemia 3. Prevention of complications - Systematic protocols reducing pneumonia, urinary tract infections, pressure ulcers, and deep vein thrombosis 4. Coordinated multidisciplinary care - Regular team meetings, shared goal-setting, and integrated treatment plans 5. Specialized nursing care - Nurses trained in stroke-specific assessment, monitoring, and management 6. Early mobilization and rehabilitation - Therapy assessment and treatment beginning within 24-48 hours 7. Family involvement and education - Structured programs supporting caregivers and preparing for discharge Comparison with Alternative Care Models Network meta-analysis comparing different stroke unit types found that dedicated stroke wards showed superior outcomes compared to general medical wards, mobile stroke teams, and mixed rehabilitation wards[web:11]. The absolute reduction in poor outcomes ranged from 3-5% for death and 7-9% for combined death or dependency, representing substantial clinical benefit when applied at population level. Time to Stroke Unit Admission The 4-hour target for stroke unit admission recognizes the importance of early access to specialized care. While most stroke unit trials did not specifically analyze admission timing, observational studies demonstrate dose-response relationships. A study of 10,977 patients found that each hour of delay to stroke unit admission was associated with increased odds of poor outcome (OR 1.03 per hour, 95% CI 1.01-1.05) [18]. Admission to stroke units was associated with a 43% reduction in prolonged hospitalization (>30 days) in one large observational study[18]. This reduction in extended stays reflects both improved outcomes and more efficient care pathways. Indicator 2.3: Spending ≥90% of Stay on Stroke Unit Rationale for Continuous Care 8 The 90% threshold recognizes that stroke patients may require temporary transfer to other units (ICU, cardiac catheterization laboratory, interventional radiology) while ensuring they receive the vast majority of their care in a specialized stroke environment. Continuous stroke unit care maximizes exposure to specialized monitoring, early complication detection, coordinated multidisciplinary management, and rehabilitation. Evidence from Stroke Unit Trials The stroke unit trials that demonstrated mortality and disability benefits provided continuous care on specialized units throughout the acute and early rehabilitation phases. The protocol in most trials specified that patients remain on the stroke unit for the majority of their hospitalization, with organized care from admission through discharge planning[9][15]. Dose-Response Relationships Studies examining the dose-response relationship between stroke unit exposure and outcomes consistently show that greater time in stroke units is associated with better outcomes. A Swedish national registry study of 54,876 patients found that each additional day on a stroke unit (as opposed to general ward) was associated with reduced mortality and improved functional outcomes[19]. Conversely, patients who are admitted to stroke units but then transferred to general wards for extended periods lose the benefits of specialized care. Analysis from the SSNAP database found that patients spending <50% of their stay on stroke units had outcomes similar to those never admitted to stroke units, while those spending >90% of stay on stroke units had the best outcomes[20]. Implementation Challenges Achieving the 90% target requires sufficient stroke unit capacity relative to patient volumes and lengths of stay. Barriers include: inadequate stroke unit beds leading to "boarding" of patients on general wards, prolonged stays of patients awaiting rehabilitation or long-term care placement, and competing demands for beds during periods of high hospital occupancy[21]. Quality improvement initiatives addressing these barriers have successfully increased the proportion of patients meeting the 90% threshold from 60-70% to 80-90% through interventions including: expansion of stroke unit capacity, implementation of early supported discharge programs to reduce average length of stay, and enhanced discharge planning[21]. Indicator 2.4: Stroke Specialist Community Rehabilitation (ESD/CRT) Early Supported Discharge Services Early Supported Discharge (ESD) services provide hospital-level multidisciplinary rehabilitation in patients' homes, enabling earlier hospital discharge while maintaining intensive therapy. ESD services typically include: assessment and goal-setting in hospital, early discharge when medically stable, home visits by a multidisciplinary stroke team (physiotherapy, occupational therapy, speech and language therapy, nursing), and coordination with primary care and community services[22]. Evidence from Randomized Controlled Trials A Cochrane systematic review of 17 trials with 2,422 participants demonstrated that ESD services: • Reduce hospital length of stay by approximately 6 days (MD -5.5 days, 95% CI -3 to -8 days) • Improve independence in activities of daily living (OR 1.44, 95% CI 1.08-1.91) 9 • Reduce odds of poor outcome (death or dependency) at 6 months (OR 0.78, 95% CI 0.65-0.94) • Achieve these benefits without increasing mortality or readmission rates[22][23] Functional Benefits ESD services produce specific improvements in functional domains including mobility, bathing, toileting, and dressing. Effect sizes range from OR 1.23 to 1.60 for different activities of daily living[24]. These gains reflect the benefits of practicing functional activities in the home environment where they will be performed long-term. A meta-analysis examining patient-level data from ESD trials found that benefits were greatest for patients with moderate disability (equivalent to modified Rankin Scale 2-3). Patients with severe disability required more intensive support, while those with mild disability recovered well regardless of setting[25]. Cost-Effectiveness ESD services demonstrate cost-effectiveness while maintaining or improving outcomes. Economic analyses from multiple countries show that ESD services reduce total healthcare costs through shorter hospital stays, while maintaining quality of life and functional outcomes[26]. The UK National Institute for Health and Care Excellence (NICE) recommends ESD services based on clinical and cost-effectiveness evidence. Requirements for Effective ESD Evidence suggests that ESD services must meet certain criteria to be effective: • Adequate staffing levels to provide intensive therapy (typically 1-2 hours daily initially) • Availability of all core disciplines (physiotherapy, occupational therapy, speech and language therapy) • Rapid response capability (able to initiate home visits within 24 hours of discharge) • Coordination with hospital teams and primary care • Duration of service (typically 6-12 weeks) • Clear eligibility criteria focusing on patients likely to benefit[22][23] ESD services with partial implementation of these components show attenuated benefits compared to fullyresourced services, emphasizing the importance of adequate infrastructure and staffing[25]. Domain 3: Reperfusion Therapies Reperfusion therapies—intravenous thrombolysis and mechanical thrombectomy—represent the most time-sensitive and potentially transformative acute stroke treatments. Domain 3 indicators measure both the rates of reperfusion therapy delivery and the speed with which these treatments are administered. Indicators 3.1-3.3: Thrombolysis Rates Evidence for Intravenous Thrombolysis Intravenous thrombolysis with tissue plasminogen activator (tPA) or tenecteplase significantly improves functional independence after ischemic stroke. The evidence base has evolved over three decades, from initial trials demonstrating efficacy within 3 hours, to extended time window trials, to recent innovations with tenecteplase. The landmark NINDS trial (1995) established that tPA administered within 3 hours of symptom onset increases the likelihood of minimal or no disability at 3 months by 30-50%[27]. Subsequent trials and 16 Early rehabilitation therapy assessment enables: • Identification of impairments requiring intervention • Baseline functional assessment for outcome measurement • Early goal-setting with patients and families • Commencement of rehabilitation during optimal plasticity window • Prevention of secondary complications (contractures, pressure ulcers, deconditioning) The 24-hour timeframe reflects evidence that earlier rehabilitation improves outcomes, while recognizing practical constraints on immediate therapy availability[43][44]. Evidence for Early Rehabilitation Multiple studies examine the timing and intensity of rehabilitation initiation: A Cochrane systematic review of very early mobilization (within 24-48 hours) found mixed results. The AVERT trial, the largest study (2,104 patients), found that very early, frequent, and intensive mobilization actually increased odds of poor outcome (OR 1.37, 95% CI 1.11-1.69)[43]. This surprising result led to recognition that "earlier" and "more intensive" are not uniformly better, and patient selection and appropriate intensity matter. Subsequent analyses clarified that early assessment and goal-setting differ from very early intensive mobilization. Early assessment (within 24 hours) followed by individualized rehabilitation tailored to patient capabilities improves outcomes[44]. The key is avoiding both prolonged inactivity and overly aggressive early mobilization. A meta-analysis of early rehabilitation (defined as beginning within 7 days) found improvements in: • Activities of daily living: standardized mean difference 6.90 (95% CI 0.22-13.57) • Motor function: standardized mean difference 5.02 (95% CI 1.63-8.40) • Walking ability and balance[45] Occupational Therapy Specific Evidence Occupational therapy focuses on activities of daily living, upper extremity function, cognitive assessment, and environmental adaptation. A systematic review of occupational therapy interventions found that: • Task-oriented training improves ADL performance (SMD 0.28, 95% CI 0.08-0.49) • Upper limb training improves arm function (SMD 0.35, 95% CI 0.17-0.53) • Cognitive rehabilitation improves executive function and memory • Environmental modifications reduce falls and improve independence[44] Physiotherapy Specific Evidence Physiotherapy addresses mobility, balance, motor control, and cardiovascular fitness. Evidence supports: • Early physiotherapy assessment and intervention reduces complications including DVT, pneumonia, and pressure ulcers • Task-specific training improves walking speed and endurance • Balance training reduces falls risk 17 • Cardiovascular fitness training improves functional capacity[45] Practical Implementation Achieving 24-hour assessment for all appropriate patients requires adequate therapy staffing, weekend availability, and efficient referral processes. Stroke units with integrated therapy teams achieve this target more consistently than units relying on referral to separate therapy departments[10]. Indicator 4.5: Speech and Language Therapy Within 72 Hours Roles of Speech and Language Therapists Speech and language therapists (SLTs) assess and treat: • Dysphagia (swallowing disorders) • Aphasia (language disorders) • Dysarthria (speech motor disorders) • Cognitive-communication disorders • Voice disorders The 72-hour timeframe for SLT assessment (compared to 24 hours for OT/PT) reflects two considerations: prioritization of immediate dysphagia assessment for patients failing swallow screening (covered under Indicator 4.2), and recognition that comprehensive communication assessment may require patient to be medically stable and alert enough to participate[46]. Evidence for Speech and Language Therapy The evidence base for SLT interventions has grown substantially, with systematic reviews demonstrating efficacy across multiple domains: For Aphasia: A Cochrane review of speech and language therapy for aphasia found: • SLT improves functional communication compared to no therapy (SMD 0.28, 95% CI 0.06-0.49) • SLT improves reading (SMD 0.29, 95% CI 0.08-0.50) and writing (SMD 0.22, 95% CI 0.01-0.44) • More intensive therapy produces greater gains (dose-response relationship) • Therapy begun within 3 months of stroke is most effective[46][47] Dosage and Intensity: Optimal therapy intensity remains an active research area. Studies demonstrate: • Frequent therapy (4-5 times per week) superior to infrequent therapy (1-2 times per week) • Higher cumulative dose (40-60 hours total) produces larger effect sizes than lower dose (<20 hours) • Combination of therapist-delivered and practice-based interventions maximizes gains • Technology-assisted therapy can augment traditional therapy to increase dose[47][48] For Dysarthria: 18 SLT interventions for dysarthria (speech motor disorders) include: • Articulation exercises improving speech intelligibility • Rate control strategies enhancing comprehensibility • Respiratory exercises supporting speech production • Augmentative communication for severely affected individuals[46] Timing Considerations The 72-hour timeframe balances multiple factors: • Immediate needs: Patients with dysphagia require assessment within 24 hours (Indicator 4.2) • Communication assessment: Comprehensive language assessment requires patient alertness and cooperation, which may take 48-72 hours to achieve in drowsy or medically unstable patients • Resource allocation: Most stroke units have limited SLT staffing, necessitating prioritization • Prognostic assessment: Early aphasia severity predicts recovery trajectory, enabling goal-setting and family counseling[47] Domain 5: Rehabilitation Pathways Domain 5 indicators measure the comprehensiveness and coordination of rehabilitation provision, recognizing that stroke recovery requires organized, goal-directed, multidisciplinary intervention over weeks to months. These indicators reflect the intensity and integration of rehabilitation services. Indicator 5.1: Coordinated Multidisciplinary Assessment Composite Indicator Components This indicator combines multiple assessment timeframes: • Nurse assessment within 4 hours (also Indicator 1.6) • Occupational therapy and physiotherapy within 24 hours (also Indicators 4.3 and 4.4) • Speech and language therapy within 72 hours (also Indicator 4.5) • Rehabilitation goals agreed within 5 days The composite nature reflects the integrated, team-based approach that characterizes effective stroke unit care. Each component is necessary but not sufficient; the coordinated delivery of all components represents optimal practice[10]. Evidence for Multidisciplinary Team Approach Multidisciplinary team working is a defining characteristic of stroke unit care. The mechanisms through which coordinated care improves outcomes include: 1. Comprehensive needs assessment - Each discipline identifies impairments and functional limitations from their specialized perspective 2. Integrated goal-setting - Team develops shared understanding of patient priorities and realistic short/medium-term goals 19 3. Coordinated interventions - Therapy programs complement rather than duplicate, with consistent approaches across disciplines 4. Regular communication - Team meetings ensure information sharing and care plan adjustment 5. Family involvement - Coordinated family education and training in techniques for supporting patient Studies examining components of stroke unit care identify coordinated multidisciplinary team meetings as a key active ingredient[10]. A systematic review found that stroke units with weekly or more frequent multidisciplinary meetings had superior outcomes compared to those with less coordinated care[15]. Goal-Setting Evidence The requirement for rehabilitation goals to be agreed within 5 days reflects evidence that structured goalsetting improves outcomes. Studies of collaborative goal-setting demonstrate: • Improved patient motivation and rehabilitation engagement • Better functional outcomes when goals are specific, measurable, and challenging • Enhanced patient and family satisfaction • More efficient resource utilization through focused interventions[49] The SMART framework (Specific, Measurable, Achievable, Relevant, Time-bound) for goal-setting is widely recommended and incorporated into stroke rehabilitation guidelines[50]. Indicators 5.2 & 5.3: NICE Target for Total Therapy Dose NICE Rehabilitation Guidelines The 2023 NICE guidelines for stroke rehabilitation recommend that patients should receive a minimum of 3 hours of multidisciplinary therapy per day, 5 days per week (total 15 hours per week)[49]. This represents cumulative time across physiotherapy, occupational therapy, and speech and language therapy. The recommendation reflects evidence for dose-response relationships in stroke rehabilitation. Evidence for High-Intensity Rehabilitation Multiple studies demonstrate that more intensive rehabilitation produces better outcomes: DOSE Trial: This pragmatic randomized controlled trial (218 patients) compared three doses of rehabilitation: • Control: usual care (approximately 30 minutes daily) • DOSE1: double usual care intensity (approximately 1 hour daily) • DOSE2: quadruple usual care intensity (approximately 2 hours daily) Results showed dose-dependent improvements in walking endurance: • Control group: 29-meter improvement in 6-minute walk distance • DOSE1 group: 61-meter improvement (95% CI 27-95 meters better than control) • DOSE2 group: 58-meter improvement (95% CI 24-92 meters better than control)[51] Benefits persisted at 12-month follow-up, demonstrating sustained effects of higher intensity rehabilitation[51]. 20 Meta-Analyses of Rehabilitation Intensity: A systematic review examining rehabilitation intensity (90-180 minutes daily) across multiple trials found: • Higher intensity associated with greater improvements in ADL (Barthel Index mean difference 5.2 points, 95% CI 0.7-9.7) • Improvements in motor function (Fugl-Meyer score mean difference 3.8 points, 95% CI 0.8-6.8) • No increase in adverse events with higher intensity • Benefits most pronounced in first 6 months post-stroke[52][53] Therapy Time Distribution: Studies examining actual therapy delivery on stroke units find wide variation: •Median total therapy time: 45-90 minutes per day across disciplines •Only 20-40% of patients receive the recommended 3 hours daily •Variation driven by patient factors (severity, fatigue, medical stability) and system factors (staffing, weekend coverage)[52] SSNAP data demonstrate that hospitals achieving higher therapy doses have better functional outcomes and shorter lengths of stay[web:3]. Barriers to Achieving Therapy Targets: Quality improvement studies identify barriers to delivering recommended therapy intensity: • Inadequate therapy staffing levels • Limited weekend and evening therapy coverage • Medical instability or fatigue limiting patient participation • Competing demands (medical procedures, investigations, appointments) • Lack of space or equipment for concurrent therapy sessions • Administrative and documentation burden reducing direct patient contact time[53] Successful strategies for increasing therapy dose include: enhanced staffing models, self-directed practice programs between supervised sessions, technology-augmented therapy, group therapy sessions, and family-assisted practice[52][53]. Domain 6: Therapy Frequency While Domain 5 measures total therapy dose, Domain 6 examines the distribution and frequency of therapy across different modalities. These indicators recognize that different impairments require targeted interventions delivered with appropriate intensity and frequency. Indicators 6.1 & 6.2: Motor Therapy Intensity (3 Hours/Day) Rationale for High-Intensity Motor Therapy 21 Motor impairments affect 80% of stroke survivors and represent primary determinants of functional independence. Evidence from animal models and human studies demonstrates that motor recovery depends on: • Repetitive task-specific practice • Adequate intensity and duration of practice • Challenge matched to current abilities (shaping) • Feedback on performance • Transfer of skills to real-world activities[54] The 3-hour daily target for motor therapy reflects evidence that higher doses produce greater motor recovery[51][54]. Evidence from High-Intensity Training Studies Task-Specific Training: Studies of task-specific training (repetitive practice of functional activities) demonstrate dose-response relationships: • Interventions providing >20 hours of task-specific practice produce clinically meaningful improvements in motor function (mean 6-point improvement on Fugl-Meyer scale) • Higher repetition counts (>300 repetitions per session) associated with greater gains • Functional tasks (e.g., reaching for objects, stepping practice) show better transfer to ADL than impairment-focused exercises[54] Constraint-Induced Movement Therapy (CIMT): CIMT, which involves intensive practice with the affected arm (6 hours daily) while constraining the unaffected arm, produces large effect sizes: • Meta-analyses show SMD 0.45 (95% CI 0.25-0.65) for upper extremity function • Modified protocols with reduced intensity (2-3 hours daily) retain substantial benefits while improving feasibility • Benefits maintained at long-term follow-up (1-2 years)[55] Aerobic Exercise Training: Cardiovascular fitness training improves walking endurance, gait speed, and functional mobility: • High-intensity interval training produces greater improvements than moderate-intensity continuous training in walking speed and endurance • Typical protocols: 20-40 minutes per session, 3-5 times weekly, for 8-12 weeks • Improvements in cardiovascular fitness correlate with functional gains[51] Frequency of Motor Therapy: Indicator 6.2 measures the percentage of inpatient days on which motor therapy is received. Evidence supports: • Daily therapy (5-7 days per week) superior to 2-3 days per week 22 • Distributed practice (multiple sessions per day) may be more effective than massed practice (single long session) • Weekend therapy provision reduces length of stay and improves outcomes[55] Indicators 6.3 & 6.4: Psychological Therapy (45 Minutes/Day) Prevalence and Impact of Post-Stroke Depression Post-stroke depression (PSD) affects 20-50% of stroke survivors and significantly impacts outcomes: • Increased mortality: HR 1.61 (95% CI 1.33-1.96)[56] • Worse functional outcomes: OR 1.64 (95% CI 1.36-1.99)[57] • Reduced rehabilitation participation and slower recovery • Lower quality of life • Increased caregiver burden[58] PSD differs from depression in other contexts, with unique features including: sudden onset following stroke event, potential association with lesion location, coexistence with cognitive impairment and aphasia, and interaction with physical disability[56]. Evidence for Depression Screening and Intervention Screening: Systematic depression screening using validated tools (e.g., Patient Health Questionnaire-9, Hospital Anxiety and Depression Scale) increases detection rates from 20-30% to 40-50%, identifying patients who might otherwise go unrecognized[58]. Early identification enables timely intervention. Pharmacological Treatment: Meta-analyses of antidepressant treatment for PSD demonstrate: • Efficacy in reducing depression symptoms (SMD -0.92, 95% CI -1.29 to -0.54) • Potential benefits for functional recovery independent of depression improvement • Best evidence for selective serotonin reuptake inhibitors (SSRIs) • Prophylactic antidepressants do not prevent PSD in unselected patients[59] Psychological Interventions: Non-pharmacological treatments for PSD include: • Cognitive-behavioral therapy (CBT): adapted for stroke patients, addresses negative thoughts and behavioral activation • Problem-solving therapy: helps patients develop coping strategies for stroke-related challenges • Motivational interviewing: enhances engagement in rehabilitation • Behavioral activation: structured activity scheduling to counteract withdrawal[59] A meta-analysis of psychological interventions found moderate effect sizes (SMD -0.50, 95% CI -0.83 to -0.17) for reducing depressive symptoms[57]. 23 Optimal Intensity of Psychological Therapy: The 45-minute daily recommendation reflects clinical guidelines, though evidence specifically validating this dose is limited. Most efficacy trials of psychological interventions used: • 30-60 minute sessions • 1-2 times weekly frequency • 8-12 week duration • Total cumulative dose of 6-12 hours[58][59] For hospitalized patients with more severe depression, daily brief interventions may be appropriate, while outpatients typically receive weekly longer sessions. Indicators 6.5 & 6.6: Communication/Swallowing Therapy (45 Minutes/Day) National Guidelines for SLT Intensity UK national guidelines recommend 45 minutes of speech and language therapy daily, five days per week, for patients with communication or swallowing deficits[60]. This reflects evidence that SLT intensity matters for outcomes, with dose-response relationships demonstrated across multiple studies. Evidence for Aphasia Therapy Intensity Dose-Response Studies: Multiple studies examine the relationship between aphasia therapy intensity and outcomes: • A systematic review found that interventions providing >5 hours per week produced larger effect sizes (SMD 0.69) than interventions providing <2 hours per week (SMD 0.25)[47] • Very high intensity (>15 hours weekly) may not produce proportionally greater gains, suggesting an optimal intensity range of 5-15 hours weekly • Cumulative dose matters: total therapy hours over weeks/months predict outcomes better than intensity alone[61] Comparative Effectiveness: The Big CACTUS trial compared two aphasia therapy approaches: • Aphasia Computer Treatment (ACT): self-directed computer practice, 20-30 minutes daily • Usual care: therapist-delivered therapy, 1-2 sessions weekly Results showed that computer-based therapy (delivering higher cumulative dose through daily practice) was non-inferior to therapist-delivered therapy, with some advantages in word-finding[62]. This supports the principle that cumulative practice dose drives outcomes, whether delivered by therapists or through structured self-practice. Dysphagia Therapy Evidence: For swallowing disorders, evidence supports: 24 • Swallowing exercises (e.g., effortful swallow, Mendelsohn maneuver) improve swallow safety and efficiency • Intensive therapy (daily sessions) reduces time to oral diet advancement • Electrical stimulation and biofeedback may augment traditional therapy • Adequate therapy dose (>3 hours weekly) associated with better outcomes[61] Frequency of Therapy: Indicator 6.6 measures the percentage of inpatient days on which communication/swallowing therapy is received. Evidence supports: •Daily practice (with or without direct therapist supervision) superior to 2-3 times weekly •Distributed practice (multiple brief sessions) may be more effective than single long sessions, particularly for swallowing exercises •Home practice programs between therapist sessions increase cumulative dose[62] Technology-Enhanced Therapy Delivery: Innovative approaches to delivering adequate therapy dose include: • Computer-based aphasia therapy programs enabling intensive practice • Telepractice delivering therapy to outpatients and rural populations • Virtual reality and gaming platforms engaging patients in speech practice • Mobile apps supporting home practice with automated feedback[47][62] These technologies address the challenge of limited therapist availability by augmenting, though not replacing, traditional therapy. Domain 7: Standards by Discharge Domain 7 indicators address important care processes and screening activities that should occur during the inpatient stay to optimize long-term outcomes and prevent complications. These indicators reflect comprehensive, patient-centered care addressing medical, functional, cognitive, and psychosocial needs. Indicator 7.1: Nutrition Screening and Dietitian Involvement Prevalence of Malnutrition After Stroke Malnutrition and nutritional risk affect 10-30% of stroke patients at hospital admission and up to 35-50% during hospitalization. Risk factors include: • Dysphagia limiting oral intake • Reduced consciousness or altered mental status • Pre-existing malnutrition in frail elderly patients • Increased metabolic demands of acute illness • Depression and reduced appetite 25 • Environmental barriers to eating (unfamiliar hospital food, assistance needed)[63] Evidence Linking Nutrition to Outcomes Nutritional status predicts stroke outcomes: The Prognostic Nutritional Index (PNI), calculated from serum albumin and lymphocyte count, independently predicts outcomes: • Low PNI (<40) associated with post-stroke cognitive impairment (OR 2.158, 95% CI 1.205-3.863) • Low PNI predicts poor functional outcomes (mRS 3-6) at 3 months • Malnutrition independently associated with increased mortality, longer length of stay, and higher complication rates[63] Nutritional Screening and Intervention Systematic nutritional screening identifies patients requiring detailed assessment and intervention. Validated tools include: • Malnutrition Universal Screening Tool (MUST) • Nutritional Risk Screening 2002 (NRS-2002) • Mini Nutritional Assessment (MNA) Patients identified as at nutritional risk require dietitian assessment and individualized nutrition care plans, which may include: • Texture-modified diets for dysphagia • Nutritional supplementation (oral supplements, fortified foods) • Feeding assistance and environmental modifications •Enteral nutrition (nasogastric or gastrostomy feeding) for severe dysphagia •Monitoring of intake and weight trends[63] Outcomes of Nutrition Interventions: Studies of systematic nutritional screening and intervention demonstrate: • Prevention of weight loss during hospitalization • Reduced pressure ulcer incidence • Improved functional recovery (conflicting evidence, may depend on intervention type) • Reduced length of stay in patients with identified nutritional risk who receive intervention[63] Indicator 7.2: Infection Rates (UTI and Pneumonia) Stroke-Associated Infections Infections represent major complications affecting 20-30% of stroke patients, with pneumonia and urinary tract infections accounting for most cases[64]. Stroke-associated infections dramatically worsen outcomes through: • Increased mortality (OR 2.3-3.0) • Prolonged hospitalization (mean 5-10 additional days) 32 Early Supported Discharge: ESD programs incorporating ongoing support and follow-up (discussed under Indicator 2.4) demonstrate better outcomes than discharge without structured follow-up. Key components include: • Designated care coordinator known to patient and family • Regular contact (phone or in-person) during transition period • Availability to address questions and concerns • Facilitation of community service access[22][25] Care Transitions Interventions: Studies of care transitions interventions (not stroke-specific) demonstrate that providing: • Named contact person reduces 30-day readmission rates • Care coordination improves medication adherence • Structured follow-up reduces emergency department visits • Patient education and activation improves self-management[78] Patient and Caregiver Perspectives: Qualitative research with stroke survivors and caregivers consistently identifies post-discharge support as a major unmet need. Patients report: • Uncertainty about who to contact with questions • Difficulty navigating fragmented services • Feeling "abandoned" after intensive hospital care • Lack of information about recovery trajectory and available resources Provision of a named contact addresses these concerns by providing a clear point of entry to the healthcare system[79]. Implementation Models: Different service models provide post-discharge support contact: • Stroke nurse specialist: provides telephone follow-up and clinic appointments • Early supported discharge team: care coordinator role • Primary care stroke liaison: GP-based support • Peer support programs: connecting with experienced stroke survivors • Voluntary sector: stroke association support workers[22][79] The optimal model likely depends on local service configuration, but the key principle is ensuring patients have a known, accessible contact for post-discharge needs. Evidence Strength Summary and Quality Grading 33 Strong Evidence (Multiple RCTs and Meta-Analyses) The following indicators have the strongest evidence base, with multiple randomized controlled trials and systematic reviews demonstrating clear improvements in mortality, disability, or other patient-important outcomes: Stroke Unit Care (Indicators 2.1, 2.2, 2.3): 29 RCTs with 5,902 participants OR 0.87 for death (95% CI 0.69-0.94) OR 0.78 for death or institutionalization (95% CI 0.68-0.89) Cochrane reviews consistently updated since 1997 Benefits sustained at 10-year follow-up[9][10][15][16][web:11][web:14] Dysphagia Screening and Assessment (Indicators 1.7, 4.2): Multiple meta-analyses demonstrating consistent benefits OR 0.52 for pneumonia (95% CI 0.35-0.77) OR 0.54 for mortality (95% CI 0.35-0.85) Strong mechanistic rationale and biological plausibility[11][12][13][14] Thrombolysis (Indicators 3.1-3.3): Nine major RCTs with 6,756 participants OR 1.64 for favorable outcome (95% CI 1.47-1.82) Time-dependent benefits well-documented Extended time window benefits proven in imaging-selected patients[27][28][29] Thrombectomy (Indicators 3.5-3.7): Multiple landmark RCTs (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT) HERMES meta-analysis: OR 2.39 for functional independence (95% CI 1.88-3.04) Benefits demonstrated across multiple time windows and patient subgroups[33][34][35][36][37] [38] Early Supported Discharge (Indicator 2.4): Cochrane review of 17 trials with 2,422 participants OR 0.78 for death or dependency (95% CI 0.65-0.94) 5.5-day reduction in hospital length of stay (95% CI -3 to -8 days) Cost-effectiveness demonstrated[22][23][24][25] Therapy Dose and Intensity (Indicators 5.2, 5.3, 6.1, 6.2): Multiple RCTs demonstrating dose-response relationships DOSE trial showing sustained benefits of higher intensity Meta-analyses consistently favoring higher doses Evidence across multiple therapy types (PT, OT, SLT)[51][52][53][54] 34 Moderate Evidence (Observational Studies and Subset Analyses) Early Imaging (Indicators 1.1, 1.2): No RCTs specifically testing imaging time targets Observational studies showing correlations with outcomes ASPECTS validation studies demonstrating prognostic value Mechanism through enabling faster treatment[1][2][3][4] CTA Use (Indicators 1.3, 1.4): No RCTs of CTA vs. no CTA (would be unethical given current knowledge) Observational studies showing improved thrombectomy rates Diagnostic accuracy studies (95% sensitivity, 98% specificity) Extended window treatment enabled by advanced imaging[5][6][7][8] Door-to-Needle Time Reduction (Indicator 3.4): Large observational studies (58,353 patients) Quality improvement studies demonstrating feasibility Clear time-outcome relationships No RCT randomizing patients to different door-to-needle times (unethical)[8][30][31][32] Early Multidisciplinary Assessment (Indicators 4.1-4.5, 5.1): Component of stroke unit care but specific timing thresholds not directly tested Observational data supporting earlier assessment AVERT trial cautionary regarding very early intensive mobilization Mechanism plausible and consistent with stroke unit benefit[43][44][45][46] Cognition Screening (Indicator 7.4): Prognostic value established No RCTs testing outcomes of screening vs. no screening Logical link to cognitive rehabilitation which has moderate evidence Oxford Cognitive Screen validation studies[69][70][71] SLT Intensity (Indicators 6.5, 6.6): Multiple studies showing dose-response relationships for aphasia therapy Fewer studies specifically testing daily therapy vs. less frequent Strong evidence for cumulative dose importance Limited evidence for swallowing therapy intensity[47][61][62] 35 Limited Direct Evidence (Expert Consensus and Guidelines) Specific Time Thresholds: Many time-based indicators (1 hour for clinician assessment, 14 hours for consultant, 4 hours for various assessments) represent expert consensus targets Evidence supports the general principle of early assessment Specific thresholds chosen based on feasibility and clinical workflow rather than explicit trials[9] [10][41] Vision Screening Protocols (Indicators 7.6, 7.7): High prevalence and impact of visual deficits established Evidence for specific interventions moderate Limited direct evidence that systematic screening improves outcomes Recommended in guidelines based on expert consensus[72][73][74][75][76][77] Named Contact Provision (Indicator 7.8): Component of successful ESD programs Patient-reported importance in qualitative studies No RCTs specifically testing named contact provision vs. none Supported by care transitions literature from other conditions[22][25][78][79] Nutrition Screening (Indicator 7.1): Malnutrition clearly predicts poor outcomes Screening identifies at-risk patients Limited evidence that screening itself (as opposed to subsequent interventions) improves outcomes Nutritional interventions have mixed evidence[63] Quality of Evidence Considerations Several factors affect the strength of evidence for SSNAP indicators: 1. Cluster vs. Individual Effects: Many indicators represent components of complex interventions (stroke unit care) where the benefit arises from the combination rather than individual elements. Isolating effects of specific components is challenging. 2. Ethical Constraints: For interventions now considered standard of care (e.g., dysphagia screening, brain imaging, stroke unit admission), conducting RCTs withholding intervention would be unethical, limiting evidence to observational studies and historical controls. 3. Time-Based Indicators: Specific time thresholds (20 minutes for imaging, 1 hour for assessment) often represent expert consensus targets based on workflow feasibility rather than empirically-tested thresholds. Evidence supports the general principle of faster is better, but optimal specific times are less certain. 36 4. Measurement Challenges: Some outcomes (patient satisfaction, confidence, knowledge) are difficult to measure rigorously, limiting evidence generation despite clinical importance. 5. System-Level Implementation: Quality improvement studies demonstrate feasibility and association with outcomes but lack randomization and control groups, limiting causal inference. National Quality Improvement and SSNAP Impact SSNAP as a Quality Improvement Tool Beyond measuring quality, SSNAP functions as a powerful quality improvement tool through several mechanisms: 1. Benchmarking: Hospitals can compare their performance against regional and national averages, identifying areas of relative weakness requiring improvement efforts[web:13]. 2. Transparency: Public reporting creates accountability and incentivizes improvement. Hospitals performing poorly face scrutiny from commissioners and patients[web:4]. 3. Best Practice Sharing: High-performing centers serve as models, with their protocols and systems studied and adapted by other centers[web:16]. 4. Research Platform: The comprehensive national dataset enables research identifying factors associated with better outcomes and testing improvement interventions[web:6]. Evidence for SSNAP Effectiveness Multiple studies have examined SSNAP's impact on stroke care quality: Improvements in Process Measures: Analysis of SSNAP data over time demonstrates sustained improvements in multiple domains: • Brain scanning within 1 hour: increased from 38% (2013) to 55% (2019) • Direct admission to stroke unit within 4 hours: increased from 46% (2013) to 58% (2019) • Thrombolysis rates: increased from 10.2% (2013) to 11.8% (2019) • Door-to-needle times: median reduced from 60 minutes (2013) to 43 minutes (2019)[web:7] Quality Improvement Collaborative Success: A recent study examining a quality improvement collaborative across a national stroke network found that structured QI efforts using SSNAP data significantly improved care pathway efficiency[web:9]: • Door to Decision time reduced by 15.97% (SE 4.29%, p<0.001) • Door to CT time significantly improved (p=0.002 and p=0.004 in two phases) • Improvements sustained over 2-year follow-up period • Bottom-up collaborative approach more effective than top-down mandates[web:9] Association with Outcomes: 37 Studies linking SSNAP process measures to outcomes demonstrate: • Higher SSNAP scores (aggregate performance) associated with lower mortality • Specific quality indicators (direct stroke unit admission, dysphagia screening, early therapy assessment) independently predict better functional outcomes • Hospitals improving SSNAP performance show corresponding outcome improvements[web:12] [web:18] International Perspective and Comparison Global Adoption of Stroke Quality Measurement Multiple countries have developed national stroke audit programmes inspired by or modeled after SSNAP: Australia: The Australian Stroke Clinical Registry (AuSCR) collects data on over 90% of stroke admissions across approximately 125 hospitals. Quality indicators overlap substantially with SSNAP, demonstrating international consensus on key quality measures. Australia has shown similar quality improvements over time associated with registry implementation[80]. United States: The Get With The Guidelines-Stroke program operated by the American Heart Association collects data from over 2,300 hospitals. While voluntary (unlike SSNAP's near-universal coverage), GWTG-Stroke has demonstrated quality improvements in participating hospitals, particularly in door-to-needle times and evidence-based medication use[8][81]. Canada: The Canadian Stroke Best Practices program provides guidelines and quality indicators aligned with international standards. Provincial registries collect data, though national coordination is less comprehensive than SSNAP. Regional variation in performance remains substantial[82]. European Countries: Many European nations have developed national or regional stroke registries, with varying coverage and indicator sets. The European Stroke Organisation has worked to harmonize quality indicators across countries to enable international comparisons and collaborative improvement efforts[83]. Comparative Performance International comparisons reveal: • Door-to-needle times: England/Wales median ~43 minutes, US median ~60 minutes, Australia median ~72 minutes (reflecting different measurement periods and system characteristics)[8][31] [80] • Thrombolysis rates: Range from 8-12% across developed healthcare systems, with variation driven by population characteristics and system organization[80][81][82] • Stroke unit access: >80% in England/Wales, 60-70% in many other countries, reflecting SSNAP's success in driving stroke unit development[web:7][83] 38 Future Directions and Evolving Evidence Emerging Quality Indicators Several areas represent potential future additions to stroke quality measurement: Atrial Fibrillation Detection: Prolonged cardiac monitoring after cryptogenic stroke detects atrial fibrillation in 10-30% of patients, enabling anticoagulation to prevent recurrent stroke. Quality indicators might include: • Percentage of patients with cryptogenic stroke receiving prolonged monitoring • Time to anticoagulation initiation for newly detected AF • Anticoagulation rates at discharge for known AF[84] Secondary Prevention Medication Optimization: While current indicators track provision of specific medications, future indicators might measure: • LDL cholesterol targets achieved at follow-up • Blood pressure control at 3 and 6 months • Medication adherence at 6 and 12 months • Lifestyle modification program participation[85] Patient-Reported Outcomes: SSNAP already collects 6-month patient-reported outcomes in a subset of patients. Future directions include: • Expanding collection to all patients • Incorporating patient-reported experience measures (satisfaction, communication quality) • Measuring participation and quality of life beyond basic functional measures • Caregiver burden and quality of life[web:3] Technology-Enhanced Rehabilitation: As rehabilitation technologies demonstrate efficacy, quality indicators might measure: • Access to technology-augmented therapy • Virtual reality rehabilitation utilization • Telerehabilitation provision for rural/homebound patients[86] Evolving Treatment Paradigms Recent clinical trials continue expanding the evidence base and may influence future quality indicators: Extended Time Window Thrombectomy: Trials demonstrating thrombectomy benefit up to 24 hours with imaging selection suggest future indicators might measure: 39 • Rates of perfusion imaging utilization • Thrombectomy rates in extended time windows • Awakening with stroke treatment rates[37][38] Tenecteplase for Thrombolysis: Trials demonstrating tenecteplase non-inferiority or superiority to alteplase may shift practice. Quality indicators would adapt to measure: • Tenecteplase adoption rates • Single bolus administration reducing treatment complexity[87] Direct Thrombectomy vs. Bridging Therapy: Trials comparing direct thrombectomy to IV thrombolysis followed by thrombectomy inform treatment protocols. Future indicators might measure: • Appropriate patient selection for direct thrombectomy • Time metrics for direct thrombectomy pathways[88] Addressing Health Inequities Emerging focus on health equity suggests future quality measurement should address disparities: • Performance stratified by socioeconomic status, race/ethnicity, and geography • Access to specialized services (thrombectomy, ESD) across populations • Language-appropriate information and support provision • Cultural competence in stroke care delivery[89] Implementation Challenges and Solutions Common Barriers to Achieving Quality Targets Healthcare systems face multiple challenges in meeting SSNAP targets: Resource Constraints: • Insufficient stroke unit beds relative to patient volumes • Limited therapy staffing preventing achievement of recommended intensity • Weekend and evening coverage gaps • Geographic workforce shortages (rural areas, less desirable locations)[90] System Organization: • Fragmented care pathways with delays at transition points • Emergency department bottlenecks slowing direct-to-stroke-unit admission • Competing demands for shared resources (CT scanners, radiology reporting) • Complex transfer arrangements for thrombectomy[91] 40 Clinical Factors: • Patient characteristics affecting eligibility for interventions • Medical comorbidities limiting therapy participation • Cognitive and language impairments affecting assessment and rehabilitation • Family/social factors complicating discharge planning[92] Successful Quality Improvement Strategies Evidence from quality improvement initiatives identifies effective strategies: System Redesign: • Pre-notification and activation systems • Direct-to-CT and direct-to-stroke-unit pathways • Parallel processing of assessments and interventions • Standardized protocols reducing variation[30][web:9] Enhanced Staffing Models: • Therapy assistance roles augmenting professional therapists • Extended hours and weekend coverage • Stroke specialist nurses coordinating care • Dedicated stroke physicians reducing consultant response times[90][91] Technology Solutions: • Telemedicine extending specialist expertise • Electronic dashboards providing real-time performance feedback • Decision support tools embedded in electronic records • Mobile apps coordinating pre-hospital and hospital teams[41][92] Collaborative Learning: • Regional networks sharing best practices • Learning collaboratives with structured improvement methodology • Inter-hospital visits and observation • Simulation training for rare but critical scenarios[web:9][web:16] Conclusions Summary of Evidence Base This comprehensive review demonstrates that the 40 SSNAP quality indicators rest on a strong foundation of clinical evidence, though the strength of evidence varies across indicators: 41 Very Strong Evidence: Stroke unit care, dysphagia screening, thrombolysis, thrombectomy, early supported discharge, and rehabilitation intensity have the most robust evidence from multiple randomized controlled trials and meta-analyses demonstrating clear improvements in mortality, disability, and quality of life. Moderate Evidence: Early imaging, advanced imaging for treatment selection, door-to-needle time optimization, and early multidisciplinary assessments are supported by large observational studies, quality improvement initiatives, and mechanistic understanding, though specific thresholds often reflect expert consensus rather than direct experimental evidence. Limited Direct Evidence: Some indicators, particularly those related to specific time thresholds, screening processes without demonstrated links to intervention effectiveness, and structural processes (named contact provision), rely primarily on expert consensus and logical inference rather than direct outcome studies. Interconnected Nature of Quality Indicators A critical insight from this review is that many SSNAP indicators are interconnected components of organized stroke systems rather than independent interventions. The stroke unit model that demonstrates such strong outcome benefits comprises multiple elements: rapid assessment, coordinated multidisciplinary care, specialized nursing, early rehabilitation, complication prevention, and systematic monitoring. Attempting to isolate the effect of individual components misses the synergistic nature of comprehensive stroke care. Similarly, achieving rapid reperfusion requires multiple coordinated processes: fast pre-hospital recognition and transport, efficient emergency department triage, rapid imaging, quick treatment decisions, and streamlined medication or procedure preparation. The time metrics measure the efficiency of these systems working together. Value of Comprehensive Quality Measurement The SSNAP framework's comprehensiveness is a key strength. By measuring 40 indicators across seven domains, SSNAP captures the multifaceted nature of quality stroke care. This approach: 1. Prevents gaming of individual metrics at the expense of overall care quality 2. Identifies specific weaknesses requiring targeted improvement 3. Reflects the complexity of stroke care delivery across acute and rehabilitation phases 4. Aligns with patient priorities encompassing survival, independence, and quality of life Impact on Stroke Care Quality Evidence demonstrates that SSNAP implementation has driven sustained improvements in stroke care quality across England, Wales, and Northern Ireland. Process measures have consistently improved yearover-year, with corresponding improvements in patient outcomes. The programme exemplifies how systematic quality measurement, transparent reporting, and continuous improvement efforts can elevate healthcare delivery at a population level[web:4][web:7][web:9]. Recommendations for Future Development 1. Continue evidence review: Regularly update quality indicators based on emerging clinical trial evidence and evolving stroke care paradigms.